Company · Strategic Roadmap 2030

A six-year path from a single polymer additive to a multi-vertical cold-chain platform.

Our roadmap is sequenced around three horizons. Horizon 1 is the SL6733 snowmaking additive — the cash-generating wedge. Horizon 2 is the next-generation polymer pipeline (DS-100 sAFGP, DS-400 ice rink). Horizon 3 is adjacent cold-chain verticals — food texture, biologic and vaccine cold chains, cell and tissue cryopreservation.

The three horizons

Horizon 1

SL6733 — Snowmaking additive

2026/27 EU lab pilots → 2027/28 first commercial seasons → 2028/29 multi-resort EU deployment. Targeting $14–29M ARR at 30% category penetration of the addressable European Alpine market.

Horizon 2

DS-100 & DS-400 — next-gen pipeline

DS-100 is a synthetic antifreeze glycoprotein (sAFGP) class designed by the AI engine and engineered to sit outside competing antifreeze-protein IP. DS-400 targets ice-rink IRI applications. Both ship through licensing, not direct distribution.

Horizon 3

Adjacent cold-chain verticals

Food texture (frozen desserts, IQF), biologic and vaccine cold chains, cell and tissue cryopreservation. Each vertical is entered through a strategic partner that holds the regulatory pathway and distribution; DeepSnow contributes the polymer IP under licence.

Platform

The AI discovery engine

The shared substrate that compounds across all three horizons. Each polymer made and assayed strengthens the next prediction. Each licence deal expands the assay dataset. Platform improvement is the multiplier.

Annual milestones, 2026 → 2030

YearHeadline milestonePipeline state
2026EU lab-pilot cohort signed; SnowLabs Italia incorporated; SL6733 polymer lot scale-up to 100 L.SL6733: pilot. DS-100/400: in silico.
2027First commercial SL6733 season (2027/28); first DS-100 candidates synthesised; DS-400 ice-rink LoI signed with chain operator.SL6733: commercial. DS-100: wet lab. DS-400: lit-search.
2028Multi-resort EU deployment; first non-EU SL6733 territory; first Horizon-3 strategic-partner conversation.SL6733: scaling. DS-100: pilot. DS-400: wet lab.
2029DS-100 first commercial licence; cold-chain platform agreement with food or biologic partner; expansion of AI discovery engine into a third polymer class.SL6733: mature. DS-100: commercial. DS-400: pilot.
2030Group platform run-rate: SL6733 mature, DS-100 scaling, DS-400 launched, Horizon-3 vertical generating first material licence revenue. Optionality for capital event evaluated by the board.